核受体
核受体辅活化子1
辅活化剂
细胞生物学
核受体辅活化子2
化学
基因表达调控
限制
转录因子
转录调控
抄写(语言学)
基因
重新调整用途
内生
视黄醇X受体
受体
核运输
计算生物学
基因表达
维甲酸
生物
基因调控网络
核受体辅活化子3
核蛋白
调节器
基因组编辑
清脆的
视黄醇X受体α
合成生物学
转录组
基因产物
锡尔图因
作者
Erik Rihtar,Tina Fink,Filip Ivanovski,Eva Koplan,Roman Jerala
标识
DOI:10.1038/s41467-026-69099-4
摘要
Cells regulate processes through protein interaction networks. Most chemically induced dimerization (CID) systems respond to exogenous molecules, limiting integration with endogenous signaling. Here, we repurpose nuclear receptor (NR) ligand-binding domains (LBDs) and coactivators to develop hormone- or clinically approved drug-responsive CIDs. Using the LBDs of TRβ, VDR, RARγ, ERβ, and GR2 with a TIF2 coactivator peptide, we constructed CIDs responsive to triiodothyronine, vitamin D, retinoic acid, estrogen, cortisol, and their antagonists. These CIDs enable two-input transcriptional switches for gene regulation. Furthermore, we design hormone-responsive liquid-liquid phase-separated (LLPS) condensates that strongly amplify transcription when exceeding a critical interaction threshold. These functional LLPS condensates provide a tunable platform for transcriptional control with up to several hundred-fold activation. Our findings offer an approach for integrating synthetic biology with physiological signaling, advancing applications in gene circuits, biosensing, and therapeutics through ligand-controlled LLPS formation. Two-input chemogenetic tools remain limited. Here, authors develop ligand-responsive systems based on human nuclear receptors, using agonists and antagonists to reversibly control protein interactions and cellular processes, including synthetic protein condensate formation to enhance transcription.
科研通智能强力驱动
Strongly Powered by AbleSci AI